Plant biotechnology in Argentina started at the end of the 1980s, leading to the development of numerous research groups in public institutions and, a decade later, to some local private initiatives. The numerous scientific and technological capacities existing in the country allowed the early constitution in 1991 of a sound genetically modified organisms biosafety regulatory system.
The first commercial approvals began in 1996, and to date, 59 events have obtained permits to be placed on the market, however, only two have been developed locally by public-private partnerships. The transgenic events developed at public institutions pursue different objectives in diverse crops.
However, once these events have been developed in laboratories, it is difficult to move toward a possible commercial approval. In this work, we analyze several reasons that could explain why local developments have not reached approvals for commercialization, highlighting aspects related to the lack of strategic vision in the institutions to focus resources on projects to develop biotechnological products.
Although progress has been made in generating regulatory rules adapted to research institutes (such as the regulations for biosafety greenhouses and ways of presenting applications), researchers still do not conceive regulatory science as a discipline. They generally prefer not to be involved in the design of regulatory field trials or regulatory issues related to the evaluation of events. In that sense, some of the aspects considered a regulatory affairs platform for the public scientific system and the reinforcement of laboratories that perform tests required under the Argentine regulation.
Role of Business Models in Funding the Biotech Industry: Global Trends and Challenges for Cuban Biotechnology.
Forty-three years after it was founded, with billions of dollars invested, the global biotech industry is still not positioned as a mature low-risk sector for the international investor com-munity.
Despite the clear commercial success of a number of leading companies and overall growth of the industry’s rev-enues, most biotech companies are not profi table and many fail to overcome the formidable barrier constituted by the high cost of the sector’s research and development. However, over the last four years, visible signs of change have appeared, which could be harbingers of an approaching turning point in this trend.
This article analyzes the historic background of the biotech in-dustry’s business models and corporate structures, as well as their impact on the industry’s fi nancial framework. It examines recent changes implemented by the sector’s main actors-in-cluding young startups, venture capital funds and big pharma companies-to mitigate fi nancial risk associated with develop-ment of new biotechnology products.
EGTA |
|||
ED0077 | Bio Basic | 25g | EUR 87.14 |
EGTA |
|||
E440150 | Toronto Research Chemicals | 100g | EUR 119 |
Description: 67-42-5 |
EGTA |
|||
B7195-1000 | ApexBio | 1 g | EUR 39 |
Description: Calcium chelator |
EGTA |
|||
A2506-100G | Biomatik Corporation | 100G | EUR 138.6 |
Description: Ultra Pure |
EGTA |
|||
A2506-10G | Biomatik Corporation | 10G | EUR 26.4 |
Description: Ultra Pure |
EGTA |
|||
A2506-25G | Biomatik Corporation | 25G | EUR 46.2 |
Description: Ultra Pure |
EGTA |
|||
GE7249 | Glentham Life Sciences | 10g | EUR 108.65 |
EGTA |
|||
GE7249-10 | Glentham Life Sciences | 10 | EUR 22.1 |
EGTA |
|||
GE7249-100 | Glentham Life Sciences | 100 | EUR 118.7 |
EGTA |
|||
GE7249-100G | Glentham Life Sciences | 100 g | EUR 180 |
EGTA |
|||
GE7249-10G | Glentham Life Sciences | 10 g | EUR 62.4 |
EGTA |
|||
GE7249-25 | Glentham Life Sciences | 25 | EUR 39.4 |
EGTA |
|||
GE7249-25G | Glentham Life Sciences | 25 g | EUR 84 |
EGTA |
|||
GE7249-50 | Glentham Life Sciences | 50 | EUR 67.2 |
EGTA |
|||
GE7249-50G | Glentham Life Sciences | 50 g | EUR 117.6 |
EGTA |
|||
T4585-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: EGTA |
EGTA |
|||
T4585-1g | TargetMol Chemicals | 1g | Ask for price |
Description: EGTA |
EGTA |
|||
T4585-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: EGTA |
EGTA |
|||
T4585-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: EGTA |
EGTA |
|||
T4585-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: EGTA |
EGTA |
|||
abx082266-100l | Abbexa | 100 µl | EUR 125 |
EGTA |
|||
abx082266-1ml | Abbexa | 1 ml | Ask for price |
EGTA |
|||
abx082266-200l | Abbexa | 200 µl | Ask for price |
EGTA |
|||
abx082565-100l | Abbexa | 100 µl | EUR 125 |
EGTA |
|||
abx082565-1ml | Abbexa | 1 ml | Ask for price |
EGTA |
|||
abx082565-200l | Abbexa | 200 µl | Ask for price |
EGTA |
|||
MBS635349-100g | MyBiosource | 100g | EUR 500 |
EGTA |
|||
MBS635349-10g | MyBiosource | 10g | EUR 185 |
EGTA |
|||
MBS635349-250g | MyBiosource | 250g | EUR 860 |
EGTA |
|||
MBS635349-25g | MyBiosource | 25g | EUR 240 |
EGTA |
|||
MBS635349-50g | MyBiosource | 50g | EUR 345 |
EGTA 99% |
|||
E00340 | Pfaltz & Bauer | 10G | EUR 228.91 |
EGTA, 99% |
|||
GE9981 | Glentham Life Sciences | 10g | EUR 275.2 |
EGTA, 99% |
|||
GE9981-10 | Glentham Life Sciences | 10 | EUR 30.9 |
EGTA, 99% |
|||
GE9981-100 | Glentham Life Sciences | 100 | EUR 150.4 |
EGTA, 99% |
|||
GE9981-100G | Glentham Life Sciences | 100 g | EUR 217.2 |
EGTA, 99% |
|||
GE9981-10G | Glentham Life Sciences | 10 g | EUR 73.2 |
EGTA, 99% |
|||
GE9981-25 | Glentham Life Sciences | 25 | EUR 53.8 |
EGTA, 99% |
|||
GE9981-250 | Glentham Life Sciences | 250 | EUR 300.5 |
EGTA, 99% |
|||
GE9981-250G | Glentham Life Sciences | 250 g | EUR 399.6 |
EGTA, 99% |
|||
GE9981-25G | Glentham Life Sciences | 25 g | EUR 100.8 |
EGTA, 99% |
|||
GE9981-50 | Glentham Life Sciences | 50 | EUR 89.3 |
EGTA, 99% |
|||
GE9981-50G | Glentham Life Sciences | 50 g | EUR 144 |
EGTA, AM |
|||
MBS8579925-10mg | MyBiosource | 10mg | EUR 570 |
EGTA, AM |
|||
MBS8579925-5x10mg | MyBiosource | 5x10mg | EUR 2495 |
EGTA-AM |
|||
HY-D0973 | MedChemExpress | 5mg | EUR 704.4 |
EGTA-AM |
|||
T13673-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: EGTA-AM |
EGTA-AM |
|||
T13673-1g | TargetMol Chemicals | 1g | Ask for price |
Description: EGTA-AM |
EGTA-AM |
|||
T13673-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: EGTA-AM |
EGTA-AM |
|||
T13673-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: EGTA-AM |
EGTA-AM |
|||
T13673-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: EGTA-AM |
EGTA-AM |
|||
MBS5754297-25mg | MyBiosource | 25mg | EUR 1230 |
EGTA-AM |
|||
MBS5754297-5x25mg | MyBiosource | 5x25mg | EUR 5395 |
EGTA (2x) Buffer |
|||
MBS565489-1mL | MyBiosource | 1mL | EUR 150 |
EGTA (2x) Buffer |
|||
MBS565489-5x1mL | MyBiosource | 5x1mL | EUR 525 |
EGTA tetrasodium salt |
|||
MBS8579926-1g | MyBiosource | 1g | EUR 280 |
EGTA tetrasodium salt |
|||
MBS8579926-5x1g | MyBiosource | 5x1g | EUR 1195 |
EGTA 100mM, pH 7.4, Sterile |
|||
40120129-1 | Glycomatrix | 50 mL | EUR 38.95 |
EGTA 100mM, pH 7.4, Sterile |
|||
40120129-2 | Glycomatrix | 100 mL | EUR 49.81 |
EGTA 100mM, pH 7.4, Sterile |
|||
40120129-3 | Glycomatrix | 250 mL | EUR 96.89 |
EGTA, Hi-LR™ |
|||
GRM1530-10G | EWC Diagnostics | 1 unit | EUR 33.64 |
Description: EGTA, Hi-LR™ |
EGTA, Hi-LR™ |
|||
GRM1530-25G | EWC Diagnostics | 1 unit | EUR 73.94 |
Description: EGTA, Hi-LR™ |
RIPA Buffer with EGTA |
|||
42020012-1 | Bio-WORLD | 250 mL | EUR 39.56 |
RIPA Buffer with EGTA |
|||
42020012-2 | Bio-WORLD | 500 mL | EUR 74.96 |
EGTA, Molecular Biology Grade |
|||
40500028-2 | Glycomatrix | 50 g | EUR 106.43 |
EGTA, Molecular Biology Grade |
|||
40500028-3 | Glycomatrix | 100 g | EUR 177.58 |
EGTA, Molecular Biology Grade |
|||
40500028-4 | Glycomatrix | 500 g | EUR 603.19 |
EGTA, Molecular Biology Grade |
|||
40500028-5 | Glycomatrix | 1 kg | EUR 912.98 |
EGTA, Molecular Biology Grade |
|||
40500028-6 | Glycomatrix | 2 kg | EUR 1687.94 |
EGTA 1M, pH 7.4, Sterile |
|||
40120127-1 | Glycomatrix | 50 mL | EUR 45.36 |
EGTA 1M, pH 7.4, Sterile |
|||
40120127-2 | Glycomatrix | 100 mL | EUR 66.59 |
EGTA 1M, pH 7.4, Sterile |
|||
40120127-3 | Glycomatrix | 500 mL | EUR 336.81 |
EGTA 1M, pH 8.0, Sterile |
|||
40120128-1 | Glycomatrix | 50 mL | EUR 45.36 |
EGTA 1M, pH 8.0, Sterile |
|||
40120128-2 | Glycomatrix | 100 mL | EUR 66.59 |
EGTA 1M, pH 8.0, Sterile |
|||
40120128-3 | Glycomatrix | 500 mL | EUR 336.81 |
EGTA 0.5M, pH 7.4, Sterile |
|||
40120370-1 | Glycomatrix | 50 mL | EUR 37.64 |
EGTA 0.5M, pH 7.4, Sterile |
|||
40120370-2 | Glycomatrix | 100 mL | EUR 66.11 |
EGTA 0.5M, pH 7.4, Sterile |
|||
40120370-3 | Glycomatrix | 250 mL | EUR 112.92 |
EGTA 0.5M, pH 7.4, Sterile |
|||
40120370-4 | Glycomatrix | 1 L | EUR 375.43 |
EGTA 0.5M, pH 8.0, Sterile |
|||
40520008-1 | Glycomatrix | 50 mL | EUR 38.95 |
EGTA 0.5M, pH 8.0, Sterile |
|||
40520008-2 | Glycomatrix | 100 mL | EUR 66.11 |
EGTA 0.5M, pH 8.0, Sterile |
|||
40520008-3 | Glycomatrix | 250 mL | EUR 112.92 |
EGTA 0.5M, pH 8.0, Sterile |
|||
40520008-4 | Glycomatrix | 1 L | EUR 375.43 |
MOPS Buffer with EGTA 10X |
|||
40120884-1 | Glycomatrix | 100 mL | EUR 33.86 |
MOPS Buffer with EGTA 10X |
|||
40120884-2 | Glycomatrix | 500 mL | EUR 85.98 |
RIPA Buffer with EDTA & EGTA |
|||
42020008-1 | Bio-WORLD | 250 mL | EUR 39.56 |
RIPA Buffer with EDTA & EGTA |
|||
42020008-2 | Bio-WORLD | 500 mL | EUR 65.37 |
EGTA AM *CAS 99590-86-0* |
|||
21005-10mg | AAT Bioquest | 10 mg | EUR 166 |
Description: EGTA AM is cell-permeable version of EGTA (ethylene glycol tetraacetic acid), a cell-permeable calcium chelator. |
EGTA AM *10 mM DMSO solution* |
|||
21006-1mL | AAT Bioquest | 1 mL | EUR 166 |
Description: EGTA AM is cell-permeable version of EGTA (ethylene glycol tetraacetic acid), a cell-permeable calcium chelator. |
MOPS Buffer with EGTA 10X, Sterile |
|||
40120885-1 | Glycomatrix | 100 mL | EUR 37.73 |
MOPS Buffer with EGTA 10X, Sterile |
|||
40120885-2 | Glycomatrix | 500 mL | EUR 111.42 |
EGTA tetrasodium salt *CAS 13368-13-3* |
|||
21007-1g | AAT Bioquest | 1 g | EUR 86 |
Description: EGTA (1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid) is a water-soluble and cell-impermeable calcium chelator. |
EGTA tetrasodium salt *10 mM aqueous solution* |
|||
21008-10mL | AAT Bioquest | 10 mL | EUR 86 |
Description: EGTA (1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid) is a water-soluble and cell-impermeable calcium chelator. |
Mg2 + -EGTA-ATPase test cassette (colorimetric method) |
|||
SH0266-1 | Jiaxing Korain Biotech Ltd (BT Labs) | 50T/25Sample | EUR 220 |
Mg2 + -EGTA-ATPase test cassette (colorimetric method) |
|||
SH0266-2 | Jiaxing Korain Biotech Ltd (BT Labs) | 100T/50Sample | EUR 280 |
Paraformaldehyde (4%) Fixative in PBS with Mg and EGTA |
|||
30450001-1 | Glycomatrix | 250 mL | EUR 29.99 |
Paraformaldehyde (4%) Fixative in PBS with Mg and EGTA |
|||
30450001-2 | Glycomatrix | 500 mL | EUR 53.99 |
2xRIPA Buffer IIII with EDTA and EGTA (pH 7.4) 2xconcentrate |
|||
RB4477 | Bio Basic | 500ml | EUR 86.1 |
Ethylene Glycol-O-O-bis-(2-Aminoethyl) N,N,N,N-Tetraacetic Acid (EGTA) extrapure, 98% |
|||
62858 | Sisco Laboratories | 10 Gms | EUR 21.38 |
Description: Part B |
Egtazic acid |
|||
463846 | MedKoo Biosciences | 50.0mg | Ask for price |
EGT1442 |
|||
MBS131659-100mg | MyBiosource | 100mg | EUR 1065 |
EGT1442 |
|||
MBS131659-500mg | MyBiosource | 500mg | EUR 2775 |
EGT1442 |
|||
MBS386480-10mg | MyBiosource | 10mg | EUR 285 |
EGT1442 |
|||
MBS386480-25mg | MyBiosource | 25mg | EUR 510 |
EGT1442 |
|||
MBS386480-5mg | MyBiosource | 5mg | EUR 220 |
EGT1442 |
|||
MBS386480-5x25mg | MyBiosource | 5x25mg | EUR 2280 |
EGT1442 |
|||
MBS5752420-10mg | MyBiosource | 10mg | EUR 260 |
EGT1442 |
|||
MBS5752420-25mg | MyBiosource | 25mg | EUR 435 |
EGT1442 |
|||
MBS5752420-2mg | MyBiosource | 2mg | EUR 175 |
EGT1442 |
|||
MBS5752420-50mg | MyBiosource | 50mg | EUR 610 |
EGT1442 |
|||
MBS5752420-5mg | MyBiosource | 5mg | EUR 210 |
Bexgliflozin (EGT1442) |
|||
B1929-1 | Biovision | each | EUR 170.4 |
Bexgliflozin (EGT1442) |
|||
B1929-5 | Biovision | each | EUR 496.8 |
Bexagliflozin?EGT1442 |
|||
MBS131294-100mg | MyBiosource | 100mg | EUR 1495 |
Recombinant Saccharomyces cerevisiae Protein EGT2 (EGT2) , partial |
|||
MBS1076136-INQUIRE | MyBiosource | INQUIRE | Ask for price |
EGTT-Scavenger for GSH/GSSG Assays (EGTT-100) |
|||
EGTT-SCVG | BioAssay Systems | 100 | EUR 89 |
Recombinant Mycobacterium smegmatis Amidohydrolase EgtC (egtC) |
|||
MBS1110091-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1120 |
Recombinant Mycobacterium smegmatis Amidohydrolase EgtC (egtC) |
|||
MBS1110091-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 735 |
Recombinant Mycobacterium smegmatis Amidohydrolase EgtC (egtC) |
|||
MBS1110091-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 900 |
Recombinant Mycobacterium smegmatis Amidohydrolase EgtC (egtC) |
|||
MBS1110091-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 880 |
Recombinant Mycobacterium smegmatis Amidohydrolase EgtC (egtC) |
|||
MBS1110091-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1050 |
Recombinant Mycobacterium tuberculosis Amidohydrolase EgtC (egtC) |
|||
MBS1046064-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1115 |
Recombinant Mycobacterium tuberculosis Amidohydrolase EgtC (egtC) |
|||
MBS1046064-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 740 |
Recombinant Mycobacterium tuberculosis Amidohydrolase EgtC (egtC) |
|||
MBS1046064-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 905 |
Recombinant Mycobacterium tuberculosis Amidohydrolase EgtC (egtC) |
|||
MBS1046064-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 890 |
Recombinant Mycobacterium tuberculosis Amidohydrolase EgtC (egtC) |
|||
MBS1046064-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1060 |
Rabbit anti-Saccharomyces cerevisiae (strain ATCC 204508/S288c)(Baker's yeast) EGT2 Polyclonal Antibody |
|||
MBS7155837-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Rabbit anti-Schizosaccharomyces pombe (strain 972/ATCC 24843)(Fission yeast) EGT1 Polyclonal Antibody |
|||
MBS7183038-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Rabbit anti-Schizosaccharomyces pombe (strain 972/ATCC 24843)(Fission yeast) EGT2 Polyclonal Antibody |
|||
MBS7183415-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Mycobacterium smegmatis Pyridoxal-phosphate-dependent protein EgtE (egtE) |
|||
MBS1184513-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1245 |
Recombinant Mycobacterium smegmatis Pyridoxal-phosphate-dependent protein EgtE (egtE) |
|||
MBS1184513-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 910 |
Recombinant Mycobacterium smegmatis Pyridoxal-phosphate-dependent protein EgtE (egtE) |
|||
MBS1184513-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 1035 |
Recombinant Mycobacterium smegmatis Pyridoxal-phosphate-dependent protein EgtE (egtE) |
|||
MBS1184513-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1095 |
Recombinant Mycobacterium smegmatis Pyridoxal-phosphate-dependent protein EgtE (egtE) |
|||
MBS1184513-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1180 |
Recombinant Mycobacterium smegmatis Histidine-specific methyltransferase EgtD (egtD) |
|||
MBS1143325-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1200 |
Recombinant Mycobacterium smegmatis Histidine-specific methyltransferase EgtD (egtD) |
|||
MBS1143325-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 850 |
Recombinant Mycobacterium smegmatis Histidine-specific methyltransferase EgtD (egtD) |
|||
MBS1143325-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 990 |
Recombinant Mycobacterium smegmatis Histidine-specific methyltransferase EgtD (egtD) |
|||
MBS1143325-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1020 |
Recombinant Mycobacterium smegmatis Histidine-specific methyltransferase EgtD (egtD) |
|||
MBS1143325-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1125 |
Recombinant Mycobacterium tuberculosis Pyridoxal-phosphate-dependent protein EgtE (egtE) |
|||
MBS1173767-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1265 |
Recombinant Mycobacterium tuberculosis Pyridoxal-phosphate-dependent protein EgtE (egtE) |
|||
MBS1173767-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 935 |
Recombinant Mycobacterium tuberculosis Pyridoxal-phosphate-dependent protein EgtE (egtE) |
|||
MBS1173767-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 1055 |
Recombinant Mycobacterium tuberculosis Pyridoxal-phosphate-dependent protein EgtE (egtE) |
|||
MBS1173767-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1125 |
Recombinant Mycobacterium tuberculosis Pyridoxal-phosphate-dependent protein EgtE (egtE) |
|||
MBS1173767-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1200 |
Recombinant Mycobacterium tuberculosis Histidine-specific methyltransferase EgtD (egtD) |
|||
MBS1224849-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1200 |
Recombinant Mycobacterium tuberculosis Histidine-specific methyltransferase EgtD (egtD) |
|||
MBS1224849-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 850 |
Recombinant Mycobacterium tuberculosis Histidine-specific methyltransferase EgtD (egtD) |
|||
MBS1224849-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 990 |
Recombinant Mycobacterium tuberculosis Histidine-specific methyltransferase EgtD (egtD) |
|||
MBS1224849-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1020 |
Recombinant Mycobacterium tuberculosis Histidine-specific methyltransferase EgtD (egtD) |
|||
MBS1224849-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1125 |
Recombinant Mycobacterium Smegmatis egtD Protein (aa 1-321) |
|||
VAng-Yyj4655-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 5091.6 |
Description: Mycobacterium Smegmatis (strain ATCC 700084 / mc(2)155) Histidine-specific methyltransferase EgtD (egtD), recombinant protein. |
Recombinant Mycobacterium Smegmatis egtD Protein (aa 1-321) |
|||
VAng-Yyj4655-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3606 |
Description: Mycobacterium Smegmatis (strain ATCC 700084 / mc(2)155) Histidine-specific methyltransferase EgtD (egtD), recombinant protein. |
Recombinant Mycobacterium Smegmatis egtD Protein (aa 1-321) |
|||
VAng-Yyj4655-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2469.6 |
Description: Mycobacterium Smegmatis (strain ATCC 700084 / mc(2)155) Histidine-specific methyltransferase EgtD (egtD), recombinant protein. |
Recombinant Mycobacterium Smegmatis egtB Protein (aa 1-428) |
|||
VAng-Yyj4891-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 5900.4 |
Description: Mycobacterium Smegmatis (strain ATCC 700084 / mc(2)155) Iron (II)-dependent oxidoreductase EgtB, recombinant protein. |
Recombinant Mycobacterium Smegmatis egtB Protein (aa 1-428) |
|||
VAng-Yyj4891-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 4167.6 |
Description: Mycobacterium Smegmatis (strain ATCC 700084 / mc(2)155) Iron (II)-dependent oxidoreductase EgtB, recombinant protein. |
Recombinant Mycobacterium Smegmatis egtB Protein (aa 1-428) |
|||
VAng-Yyj4891-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2848.8 |
Description: Mycobacterium Smegmatis (strain ATCC 700084 / mc(2)155) Iron (II)-dependent oxidoreductase EgtB, recombinant protein. |
Recombinant Mycobacterium Smegmatis egtC Protein (aa 1-227) |
|||
VAng-Yyj4892-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 4365.6 |
Description: Mycobacterium Smegmatis (strain ATCC 700084 / mc(2)155) Amidohydrolase EgtC (egtC), recombinant protein. |
Recombinant Mycobacterium Smegmatis egtC Protein (aa 1-227) |
|||
VAng-Yyj4892-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3129.6 |
Description: Mycobacterium Smegmatis (strain ATCC 700084 / mc(2)155) Amidohydrolase EgtC (egtC), recombinant protein. |
Recombinant Mycobacterium Smegmatis egtC Protein (aa 1-227) |
|||
VAng-Yyj4892-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2122.8 |
Description: Mycobacterium Smegmatis (strain ATCC 700084 / mc(2)155) Amidohydrolase EgtC (egtC), recombinant protein. |
Recombinant Mycobacterium Smegmatis egtE Protein (aa 1-371) |
|||
VAng-Yyj4893-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 5470.8 |
Description: Mycobacterium Smegmatis (strain ATCC 700084 / mc(2)155) Pyridoxal-phosphate-dependent protein EgtE (egtE), recombinant protein. |
Recombinant Mycobacterium Smegmatis egtE Protein (aa 1-371) |
|||
VAng-Yyj4893-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3870 |
Description: Mycobacterium Smegmatis (strain ATCC 700084 / mc(2)155) Pyridoxal-phosphate-dependent protein EgtE (egtE), recombinant protein. |
Recombinant Mycobacterium Smegmatis egtE Protein (aa 1-371) |
|||
VAng-Yyj4893-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2650.8 |
Description: Mycobacterium Smegmatis (strain ATCC 700084 / mc(2)155) Pyridoxal-phosphate-dependent protein EgtE (egtE), recombinant protein. |
Recombinant Echinococcus Granulosus EgTrpA Protein (aa 1-278) |
|||
VAng-Ly4003-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 4761.6 |
Description: Echinococcus Granulosus tropomyosin A (EgTrpA), recombination protein. |
Recombinant Echinococcus Granulosus EgTrpA Protein (aa 1-278) |
|||
VAng-Ly4003-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3376.8 |
Description: Echinococcus Granulosus tropomyosin A (EgTrpA), recombination protein. |
Recombinant Echinococcus Granulosus EgTrpA Protein (aa 1-278) |
|||
VAng-Ly4003-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2304 |
Description: Echinococcus Granulosus tropomyosin A (EgTrpA), recombination protein. |
Recombinant Mycobacterium smegmatis Iron (II)-dependent oxidoreductase EgtB |
|||
MBS1135713-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1300 |
Recombinant Mycobacterium smegmatis Iron (II)-dependent oxidoreductase EgtB |
|||
MBS1135713-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 980 |
Recombinant Mycobacterium smegmatis Iron (II)-dependent oxidoreductase EgtB |
|||
MBS1135713-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 1090 |
Recombinant Mycobacterium smegmatis Iron (II)-dependent oxidoreductase EgtB |
|||
MBS1135713-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1145 |
Recombinant Mycobacterium smegmatis Iron (II)-dependent oxidoreductase EgtB |
|||
MBS1135713-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1240 |
Finally, it discusses the challenges and opportunities that these tendencies entail for Cuban biotechnology development and proposes adoption of business policies more tolerant of the fi nancial risk inherent in this sector, as a condition for at-tracting venture capital. KEYWORDS Biotechnology, fund raising, risk management, entrepreneurship, Cuba.